Donna Kowalski

1.6k total citations
35 papers, 1.2k citations indexed

About

Donna Kowalski is a scholar working on Infectious Diseases, Epidemiology and Surgery. According to data from OpenAlex, Donna Kowalski has authored 35 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Infectious Diseases, 10 papers in Epidemiology and 9 papers in Surgery. Recurrent topics in Donna Kowalski's work include Antifungal resistance and susceptibility (11 papers), Cardiac electrophysiology and arrhythmias (9 papers) and Pneumocystis jirovecii pneumonia detection and treatment (6 papers). Donna Kowalski is often cited by papers focused on Antifungal resistance and susceptibility (11 papers), Cardiac electrophysiology and arrhythmias (9 papers) and Pneumocystis jirovecii pneumonia detection and treatment (6 papers). Donna Kowalski collaborates with scholars based in United States, Japan and Netherlands. Donna Kowalski's co-authors include Amit Desai, Robert Townsend, James J. Keirns, Takao Yamazaki, Christopher Lademacher, Shahzad Akhtar, E. Marcel van Gelderen, Marek Malík, Laura Kovanda and Salim Mujais and has published in prestigious journals such as Gastroenterology, American Journal of Respiratory and Critical Care Medicine and Antimicrobial Agents and Chemotherapy.

In The Last Decade

Donna Kowalski

35 papers receiving 1.2k citations

Peers

Countries citing papers authored by Donna Kowalski

Since Specialization

Citations

This map shows the geographic impact of Donna Kowalski's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Donna Kowalski with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Donna Kowalski more than expected).

Fields of papers citing papers by Donna Kowalski

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Donna Kowalski. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Donna Kowalski. The network helps show where Donna Kowalski may publish in the future.

Co-authorship network of co-authors of Donna Kowalski

This figure shows the co-authorship network connecting the top 25 collaborators of Donna Kowalski. A scholar is included among the top collaborators of Donna Kowalski based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Donna Kowalski. Donna Kowalski is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Exposure-Response Relationships for Isavuconazole in Patients with Invasive Aspergillosis and Other Filamentous Fungi 2017 ·Antimicrobial Agents and Chemotherapy ·Amit Desai, Laura Kovanda, William Hope, David R. Andes, Johan W. Mouton, Donna Kowalski, Robert Townsend, Salim Mujais, Peter L. Bonate	81
2	Pharmacokinetics and Safety of Amenamevir in Healthy Subjects: Analysis of Four Randomized Phase 1 Studies 2017 ·Advances in Therapy ·(unknown), James J. Keirns, Donna Kowalski, (unknown), (unknown), (unknown), Yoshiaki Ohtsu, Masataka Katashima	20
3	The Influence of Hepatic and Renal Impairment on the Pharmacokinetics of a Treatment for Herpes Zoster, Amenamevir (ASP2151): Phase 1, Open-Label, Single-Dose, Parallel-Group Studies 2017 ·Advances in Therapy ·(unknown), Donna Kowalski, (unknown), Kota Kato, Masataka Katashima, James J. Keirns, (unknown), Kenneth C. Lasseter, Thomas Marbury, Richard A. Preston	10
4	Phase I trial to investigate the effect of renal impairment on isavuconazole pharmacokinetics 2017 ·European Journal of Clinical Pharmacology ·Robert Townsend, Shahzad Akhtar, Harry Alcorn, Jolene Kay Berg, Donna Kowalski, Salim Mujais, Amit Desai	31
5	QT Interval Shortening With Isavuconazole:In VitroandIn VivoEffects on Cardiac Repolarization 2017 ·Clinical Pharmacology & Therapeutics ·James J. Keirns, Amit Desai, Donna Kowalski, Christopher Lademacher, Salim Mujais, Barbara A. Parker, (unknown), Robert Townsend, (unknown), Takaharu Yamazaki, Mark Yen, (unknown)	59
6	Pharmacokinetic Interaction Between Isavuconazole and a Fixed‐Dose Combination of Lopinavir 400 mg/Ritonavir 100 mg in Healthy Subjects 2016 ·Clinical Pharmacology in Drug Development ·Takao Yamazaki, Amit Desai, David Han, Kota Kato, Donna Kowalski, Shahzad Akhtar, Christopher Lademacher, Laura Kovanda, Robert Townsend	23
7	Pharmacokinetic and Pharmacodynamic Evaluation of the Drug‐Drug Interaction Between Isavuconazole and Warfarin in Healthy Subjects 2016 ·Clinical Pharmacology in Drug Development ·Amit Desai, Takao Yamazaki, (unknown), Donna Kowalski, Christopher Lademacher, (unknown), Shahzad Akhtar, Robert Townsend	22
8	Reproducibility of QTc interval changes after meal intake 2015 ·Journal of Electrocardiology ·Katerina Hnatkova, Donna Kowalski, James J. Keirns, E. Marcel van Gelderen, Marek Malík	8
9	Safety and tolerability of intravenous regadenoson in healthy subjects: A randomized, repeat-dose, placebo-controlled study 2015 ·Journal of Nuclear Cardiology ·Robert Townsend, Amit Desai, (unknown), Donna Kowalski, (unknown), Therese M. Kitt	8
10	QTc changes after meal intake: Sex differences and correlates 2014 ·Journal of Electrocardiology ·Katerina Hnatkova, Donna Kowalski, James J. Keirns, E. Marcel van Gelderen, Marek Malík	12
11	Role of Cytochrome P450 Isoenzymes 3A and 2D6 in the In Vivo Metabolism of Mirabegron, a β3-Adrenoceptor Agonist 2013 ·Clinical Drug Investigation ·Jennifer Lee, Selina Moy, John Meijer, Walter Krauwinkel, Taiji Sawamoto, (unknown), Donna Kowalski, Michael J. Roy, (unknown), (unknown), Marcel van Gelderen, James J. Keirns	23
12	A Phase 1, Randomized Ascending Single-Dose Study of Antagonist Anti-Human CD40 ASKP1240 in Healthy Subjects 2013 ·American Journal of Transplantation ·Ronald Goldwater, James J. Keirns, (unknown), R. First, (unknown), (unknown), Donna Kowalski, Atsunori Kaibara, John Holman	58
13	Effects of Food Intake on the Pharmacokinetic Properties of Mirabegron Oral Controlled-Absorption System: A Single-Dose, Randomized, Crossover Study in Healthy Adults 2013 ·Clinical Therapeutics ·Jennifer Lee, Wenhui Zhang, Selina Moy, Donna Kowalski, (unknown), Marcel van Gelderen, Taiji Sawamoto, Nicole Grunenberg, James J. Keirns	17
14	Importance of subject-specific QT/RR curvatures in the design of individual heart rate corrections of the QT interval 2012 ·Journal of Electrocardiology ·Marek Malík, Katerina Hnatkova, Donna Kowalski, James J. Keirns, E. Marcel van Gelderen	27
15	Effect of Renal or Hepatic Impairment on the Pharmacokinetics of Mirabegron 2012 ·Clinical Drug Investigation ·James Dickinson, (unknown), Taiji Sawamoto, Walter Krauwinkel, Marloes Schaddelee, James J. Keirns, (unknown), Selina Moy, John Meijer, Donna Kowalski, Richard E. Morton, Kenneth C. Lasseter, Dennis Riff, Viera Kupčová, Marcel van Gelderen	24
16	Proarrhythmic Safety of Repeat Doses of Mirabegron in Healthy Subjects: A Randomized, Double-Blind, Placebo-, and Active-Controlled Thorough QT Study 2012 ·Clinical Pharmacology & Therapeutics ·Marek Malík, E. Marcel van Gelderen, (unknown), Donna Kowalski, Mark Yen, Ronald Goldwater, Salim Mujais, Marloes Schaddelee, (unknown), Atsunori Kaibara, Selina Moy, James J. Keirns	112
17	Single dose pharmacokinetics and absolute bioavailability of mirabegron, a ?3-adrenoceptor agonist for treatment of overactive bladder 2012 ·International Journal of Clinical Pharmacology and Therapeutics ·(unknown), Jennifer Lee, Marloes Schaddelee, Wenhui Zhang, (unknown), John Meijer, Sjoerd van Marle, Nicole Grunenberg, Donna Kowalski, Ted Drogendijk, Selina Moy, (unknown), Marcel van Gelderen, Hiroshi Matsushima, Taiji Sawamoto	42
18	Safety, Pharmacokinetic, and Pharmacodynamic Profiles of Ipragliflozin (ASP1941), a Novel and Selective Inhibitor of Sodium-Dependent Glucose Co-Transporter 2, in Patients with Type 2 Diabetes Mellitus 2011 ·Diabetes Technology & Therapeutics ·Sherwyn Schwartz, (unknown), (unknown), Donna Kowalski, Wenhui Zhang, Wim Wilpshaar	58
19	Inhaled Misoprostol Blocks Guinea Pig Antigen-Induced Bronchoconstriction and Airway Inflammation 1996 ·American Journal of Respiratory and Critical Care Medicine ·William G. Smith, Janice Thompson, Donna Kowalski, John P. McKearn	12
20	Polymer delivery of the active isomer of misoprostol: a solution to the intestinal side effect problem. 1994 ·Journal of Pharmacology and Experimental Therapeutics ·William E. Perkins, Roberto Bianchi, Samuel J. Tremont, Paul W. Collins, (unknown), (unknown), (unknown), (unknown), James C. Stolzenbach, Donna Kowalski	7

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact